Shaily Engineering Plastics Limited (SEPL) has reported strong financial results for the second quarter of fiscal year 2026, demonstrating significant growth and expansion in its healthcare segment. The company's strategic focus on innovative drug delivery devices, particularly for GLP-1 medications, has driven its performance.

Financial Highlights

• Revenue grew by 34% year-on-year to INR 257.00 crores in Q2 FY26
• EBITDA doubled to INR 82.00 crores, with margins expanding by 1,030 basis points to 31.80%
• Profit After Tax (PAT) increased by 134% to INR 51.00 crores, with margins improving by 860 basis points to 20.00%

Segment Performance

The healthcare segment has shown remarkable growth, now contributing 38% to the overall revenue mix, doubling from the previous year.

Operational Highlights

• SEPL processed 6,652 tons of polymers in Q2 FY26, a 7.5% increase from Q2 FY25
• Machine utilization rate stands at 48% in both Q2 and H1 FY26
• Exports accounted for 68% of total revenue in Q2 FY26

Strategic Developments

Healthcare Segment Expansion

• Launched next-generation GLP-1 device, Shaily Axiom Max
• Signed four new projects across GLP-1 and other therapies
• Installed 19 new machines at manufacturing facilities

Capacity Expansion

• Increasing pen manufacturing capacity from 40 million to 80 million units by end of FY26
• Investing approximately INR 125.00 crores for capacity expansion in FY26

Consumer Segment

• Awarded 5 new projects from 3 marquee home furnishings customers

Industrial Segment

• Secured 1 new project from an automotive major

Consumer Electronics

• Expected to begin revenue generation in H2 FY26

Future Outlook

• Healthcare segment projected to grow at over 30-40% annually for the next few years
• Exploring opportunities in semiconductor business
• Potential for significant growth in Consumer Electronics segment by FY28

Amit Sanghvi, Managing Director of SEPL, commented on the results: "We have delivered strong revenue growth of 34% to INR 257.00 crores on a year-on-year basis, with EBITDA margins expanding by over 1,000 basis points to 31.80%. The growth is attributable to improved traction in our Healthcare segment, which showed a growth of 163% on a year-on-year basis to INR 98.60 crores."

The company's focus on innovation and expansion in the healthcare segment, particularly in drug delivery devices for GLP-1 medications, positions it well for continued growth. With ongoing capacity expansion and new product developments, Shaily Engineering Plastics appears poised for sustained performance in the coming years.

Investors should note that while the company's growth trajectory is impressive, market conditions and regulatory approvals, especially in international markets like Canada, may impact future performance. The management remains optimistic about the company's prospects across its diverse business segments.

Shaily Engineering Plastics Limited , a leading manufacturer of customized plastic components, has reported strong financial results for the second quarter ended September 30, 2025, showcasing significant growth across key metrics.

Financial Highlights

The company's consolidated financial results for Q2 FY2026 reveal impressive year-over-year growth:

Key Performance Indicators

Revenue Growth

The company's consolidated revenue from operations increased by 14% to ₹246.00 crore, up from ₹216.21 crore in the same quarter last year. This growth indicates strong demand for Shaily Engineering Plastics' products and effective market strategies.

Profit Increase

Net profit after tax saw a significant rise of 26.84%, reaching ₹52.55 crore compared to ₹41.43 crore in the previous year's Q2. This increase in profitability underscores the company's improved operational efficiency and cost management.

Earnings Per Share

Basic earnings per share (EPS) for the quarter stood at ₹11.44, a 26.83% increase from ₹9.02 in the same quarter last year, reflecting the company's enhanced profitability on a per-share basis.

Half-Year Performance

For the half-year period ended September 30, 2025, Shaily Engineering Plastics reported consolidated revenue of ₹492.01 crore, compared to ₹423.30 crore in the corresponding period of the previous year, representing a growth of 16.23%.

Company Overview

Shaily Engineering Plastics Limited specializes in manufacturing customized components of plastic and other materials. The company operates in a single business segment and has demonstrated consistent growth and innovation in its field.

Board Approval

The Board of Directors approved these unaudited standalone and consolidated financial results in their meeting held on November 8, 2025.

Conclusion

Shaily Engineering Plastics' robust Q2 performance demonstrates its resilience and adaptability in a dynamic market environment. The significant improvements across all financial metrics suggest that the company's strategic initiatives and focus on operational excellence are yielding positive results.

The substantial increase in profit and revenue positions Shaily Engineering Plastics favorably for continued growth. As the company leverages its manufacturing expertise in customized plastic components, it appears well-equipped to capitalize on market opportunities.